Published in Stroke on February 01, 2007
Reactive gliosis and the multicellular response to CNS damage and disease. Neuron (2014) 2.08
Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A (2011) 1.66
Two-component protein-engineered physical hydrogels for cell encapsulation. Proc Natl Acad Sci U S A (2009) 1.63
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol (2012) 1.60
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51
Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil Neural Repair (2010) 1.50
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model. PLoS One (2015) 1.39
Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 1.37
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J Stroke Cerebrovasc Dis (2011) 1.27
Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev (2010) 1.26
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther (2013) 1.24
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage (2008) 1.20
The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging (2009) 1.19
Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue. Exp Transl Stroke Med (2010) 1.13
Purification of immature neuronal cells from neural stem cell progeny. PLoS One (2011) 1.11
Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab (2010) 1.09
The use of animal models for stroke research: a review. Comp Med (2011) 1.07
Mesenchymal stem cell transplantation in multiple sclerosis. J Neurol Sci (2013) 1.04
Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab (2012) 1.03
In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model. PLoS One (2013) 1.01
Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med (2012) 1.01
Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci (2012) 0.99
Neural precursor cells in the ischemic brain - integration, cellular crosstalk, and consequences for stroke recovery. Front Cell Neurosci (2014) 0.98
Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics (2011) 0.98
Brain Aging and Regeneration after Injuries: an Organismal approach. Aging Dis (2011) 0.97
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci (2014) 0.94
Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med (2012) 0.92
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proc Natl Acad Sci U S A (2014) 0.92
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol (2013) 0.91
Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke. Stem Cells Transl Med (2012) 0.91
Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J Cell Mol Med (2012) 0.90
Perspectives for computational modeling of cell replacement for neurological disorders. Front Comput Neurosci (2013) 0.88
Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia. Exp Transl Stroke Med (2010) 0.88
Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability. Front Cell Neurosci (2014) 0.88
The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther (2015) 0.88
Delivery of iPS-NPCs to the Stroke Cavity within a Hyaluronic Acid Matrix Promotes the Differentiation of Transplanted Cells. Adv Funct Mater (2014) 0.88
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS One (2014) 0.88
In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One (2013) 0.88
Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Trials (2013) 0.87
Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke. Biomatter (2013) 0.87
Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J Cell Biochem (2011) 0.87
Injectable Hydrogels with In Situ Double Network Formation Enhance Retention of Transplanted Stem Cells. Adv Funct Mater (2015) 0.87
Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One (2011) 0.86
The possible roles of brain pericytes in brain ischemia and stroke. Cell Mol Neurobiol (2011) 0.85
Cell-based therapy for stroke. J Neural Transm (Vienna) (2010) 0.85
Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One (2015) 0.85
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
New endovascular method for transvascular exit of arteries and veins: developed in simulator, in rat and in rabbit with full clinical integration. PLoS One (2010) 0.84
Systemic delivery of umbilical cord blood cells for stroke therapy: a review. Restor Neurol Neurosci (2009) 0.84
Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice. Cell Death Dis (2014) 0.83
Therapeutic benefit of intravenous administration of human umbilical cord blood- mononuclear cells following intracerebral hemorrhage in rat. Iran J Basic Med Sci (2012) 0.82
Regenerative cellular therapies for neurologic diseases. Brain Res (2015) 0.82
Stem cells decreased neuronal cell death after hypoxic stress in primary fetal rat neurons in vitro. Cell Transplant (2011) 0.82
Autologous bone marrow stromal cell transplantation for central nervous system disorders - recent progress and perspective for clinical application. J Stem Cells Regen Med (2011) 0.82
A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke. Front Cell Neurosci (2014) 0.82
Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke. Cell Mol Neurobiol (2014) 0.82
Non-hematopoietic stem cells in umbilical cord blood. Int J Stem Cells (2009) 0.81
In vivo imaging of embryonic stem cell therapy. Eur J Nucl Med Mol Imaging (2010) 0.81
Efficacy of single and multiple injections of human umbilical tissue-derived cells following experimental stroke in rats. PLoS One (2013) 0.81
Physically associated synthetic hydrogels with long-term covalent stabilization for cell culture and stem cell transplantation. Adv Mater (2011) 0.80
Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats. Mol Cells (2013) 0.80
High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochir Suppl (2013) 0.80
Biomaterial Applications in Cell-Based Therapy in Experimental Stroke. Stem Cells Int (2016) 0.78
Stem cell therapy in intracerebral hemorrhage rat model. World J Stem Cells (2015) 0.78
Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1. Dialogues Clin Neurosci (2011) 0.78
Multimodality molecular imaging of stem cells therapy for stroke. Biomed Res Int (2013) 0.78
Ethical perspectives on knowledge translation in rehabilitation. Arch Phys Med Rehabil (2012) 0.78
Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci (2014) 0.78
Neuronal cell reconstruction with umbilical cord blood cells in the brain hypoxia-ischemia. Iran Biomed J (2015) 0.77
Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering. Acta Biomater (2016) 0.77
Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton's Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study. Cell Mol Neurobiol (2015) 0.77
Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report. Int J Mol Sci (2015) 0.77
Stem cell transplantation for treating stroke: status, trends and development. Neural Regen Res (2014) 0.77
Therapeutic potential of umbilical cord blood stem cells on brain damage of a model of stroke. J Cardiovasc Thorac Res (2011) 0.77
Pre-differentiation of human neural stem cells into GABAergic neurons prior to transplant results in greater repopulation of the damaged brain and accelerates functional recovery after transient ischemic stroke. Stem Cell Res Ther (2015) 0.76
Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential. Oncotarget (2016) 0.76
Stichopus japonicus Polysaccharide, Fucoidan, or Heparin Enhanced the SDF-1α/CXCR4 Axis and Promoted NSC Migration via Activation of the PI3K/Akt/FOXO3a Signaling Pathway. Cell Mol Neurobiol (2016) 0.76
Stem cell transplantation enhances endogenous brain repair after experimental stroke. Neurol Med Chir (Tokyo) (2015) 0.76
Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. J Neurosci (2016) 0.76
Electro-acupuncture at Conception and Governor vessels and transplantation of umbilical cord blood-derived mesenchymal stem cells for treating cerebral ischemia/reperfusion injury. Neural Regen Res (2014) 0.75
Advances in cord blood transplants in adults. F1000 Med Rep (2010) 0.75
Isolation of Human Neural Stem Cells from the Amniotic Fluid with Diagnosed Neural Tube Defects. Stem Cells Dev (2015) 0.75
Effects of neural differentiation maturity status of human induced pluripotent stem cells prior to grafting in a subcortical ischemic stroke model. Neurol Psychiatry Brain Res (2016) 0.75
Targeting the vasculature to improve neural progenitor transplant survival. Transl Neurosci (2015) 0.75
Intraventricular Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells via Ommaya Reservoir in Persistent Vegetative State Patients after Haemorrhagic Stroke: Report of Two Cases & Review of the Literature. J Stem Cells Regen Med (2016) 0.75
Prospects of modeling poststroke epileptogenesis. J Neurosci Res (2016) 0.75
Niche astrocytes promote the survival, proliferation and neuronal differentiation of co-transplanted neural stem cells following ischemic stroke in rats. Exp Ther Med (2016) 0.75
Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering. J Cereb Blood Flow Metab (2017) 0.75
Human neural stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients. Stem Cells Dev (2017) 0.75
The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review. Mol Neurobiol (2016) 0.75
Comparison of Nutech Functional Score with European Stroke Scale for Patients with Cerebrovascular Accident Treated with Human Embryonic Stem Cells: NFS for CVA Patients Treated with hESCs. J Vasc Interv Neurol (2017) 0.75
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Arteriovenous malformations. Lancet (2002) 3.15
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab (2007) 1.57
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke (2005) 1.54
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg (2011) 1.49
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Propionibacterium acnes infections after cranial neurosurgery. Can J Neurol Sci (2006) 1.42
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 1.37
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36
Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab (2004) 1.36
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Neural progenitor cells regulate microglia functions and activity. Nat Neurosci (2012) 1.34
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A (2011) 1.32
Vein of Galen malformation. Neurosurg Focus (2009) 1.28
Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol (2003) 1.27
Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab (2002) 1.21
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys. Exp Neurol (2005) 1.17
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery (2005) 1.16
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol (2002) 1.12
Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab (2005) 1.12
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus (2009) 1.10
Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery (2003) 1.10
Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant (2004) 1.09
Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab (2010) 1.09
Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg (2003) 1.08
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol (2013) 1.05
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg (2007) 1.05
Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol (2004) 1.04
Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery (2008) 1.04
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus (2009) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery (2012) 1.03
Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery (2013) 1.03
Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03
Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke (2012) 1.03
Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis (2002) 1.02
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
Neurosurgical advances in the treatment of moyamoya disease. Stroke (2011) 1.02
Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus (2009) 1.01
Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab (2008) 1.00
Fast contrast-enhanced MR whole-brain venography. Neuroradiology (2002) 1.00
Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet (2011) 0.99
Positron emission tomography imaging of poststroke angiogenesis. Stroke (2008) 0.99
Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke (2012) 0.99
Patients with moyamoya disease presenting with movement disorder. J Neurosurg Pediatr (2010) 0.99
FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem (2008) 0.99
Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant (2009) 0.98
Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke (2007) 0.98
Potential of adult neural stem cells in stroke therapy. Regen Med (2008) 0.98
Endovascular treatment of posterior circulation cerebral aneurysms by using Guglielmi detachable coils: a 10-year single-center experience with special regard to technical development. AJNR Am J Neuroradiol (2005) 0.98
Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release. Stroke (2004) 0.97
Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus (2009) 0.97
Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2010) 0.96
Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab (2002) 0.96
Hypothermia blocks beta-catenin degradation after focal ischemia in rats. Brain Res (2008) 0.96
Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant (2013) 0.94
Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats. J Neurosurg (2002) 0.93
Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary (2009) 0.92
Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke (2006) 0.91
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol (2013) 0.91